News

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

Media Alert

QuantuMDx receives CTDA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay

NEWCASTLE UPON TYNE, UK 13 December, 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay, has been approved for sale in the UK under The Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…

Media Alert

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform

Agreement will initially cover the UK and France with potential to expand to other European…

Media Alert

QuantuMDx Enters into Cooperation Agreement with Sansure Biotech

The agreement sets a roadmap for the commercialisation of Q-POC™ and its assays in ChinaThe…

Media Alert

QuantuMDx announces forthcoming webinar: Rising to the challenge: diagnosing, treating and managing respiratory infections using rapid PCR testing at the Point of Need

NEWCASTLE UPON TYNE, UK, 5 July 2022. QuantuMDx Group Limited (“QuantuMDx”) will be offering insights and advice on tackling respiratory infections in the wake of the pandemic during a webinar later this month. A panel, comprising of leading experts, will…

A supercharged platform, with a fast workflow

A smooth user experience behind each interaction, with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Need.

High quality multiplex PCR testing with the simplicity and speed of a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the ongoing pandemic with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Need.

As simple as performing lateral flow tests

Results you can trust and rely on

Decisions you can make at first glance

Confidence in all your decisions

A quality Rapid COVID-19 PCR assay that provides results with the simplicity and hands on time of a lateral flow test.

News

QuantuMDx receives CTDA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform

QuantuMDx Enters into Cooperation Agreement with Sansure Biotech

QuantuMDx announces forthcoming webinar: Rising to the challenge: diagnosing, treating and managing respiratory infections using rapid PCR testing at the Point of Need

Q-POC Platform

Q-POC™ SARS-CoV-2 Flu A/B RSV Assay

Q-POC™ SARS-CoV-2